Rehmann Capital Advisory Group’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $248K | Sell |
|
|||||
|
2024
Q3 | $229K | Sell |
|
|||||
|
2024
Q2 | $264K | Buy |
|
|||||
|
2024
Q1 | $252K | Sell |
|
|||||
|
2023
Q4 | $228K | Hold |
|
|||||
|
2023
Q3 | $243K | Sell |
|
|||||
|
2023
Q2 | $282K | Sell |
|
|||||
|
2023
Q1 | $263K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $201K | Buy |
|
|||||
|
2022
Q2 | $239K | Sell |
|
|||||
|
2022
Q1 | $334K | Sell |
|
|||||
|
2021
Q4 | $389K | Sell |
|
|||||
|
2021
Q3 | $355K | Sell |
|
|||||
|
2021
Q2 | $309K | Buy |
|
|||||
|
2021
Q1 | $231K | Sell |
|
|||||
|
2020
Q4 | $234K | Buy |
|
|||||
|
2020
Q3 | $210K | Buy |
|
|||||
|
2019
Q3 | $92K | Hold |
|
|||||
|
2019
Q2 | $81.2K | Hold |
|
|||||
|
2019
Q1 | $71.5K | Buy |
|
|||||
|
2018
Q4 | $62.2K | Hold |
|
|||||
|
2018
Q3 | $78.4K | Buy |
|
|||||
|
2018
Q2 | $59.9K | Sell |
|
|||||
|
2018
Q1 | $56K | Buy |
|